- US-listed companies
- REPLIGEN CORP
- Financials
- Capital expenditures
REPLIGEN CORPRGEN
Market cap
$8.9B
P/E ratio
| Period End | Capital expenditures (Million USD) | YoY (%) |
|---|---|---|
| Dec 31, 2024 | -26 | -29.11% |
| Dec 31, 2023 | -36 | -57.30% |
| Dec 31, 2022 | -85 | +26.45% |
| Dec 31, 2021 | -67 | +198.77% |
| Dec 31, 2020 | -22 | +21.35% |
| Dec 31, 2019 | -19 | +73.99% |
| Dec 31, 2018 | -11 | +94.99% |
| Dec 31, 2017 | -5 | +26.10% |
| Dec 31, 2016 | -4 | +64.57% |
| Dec 31, 2015 | -3 | -53.09% |
| Dec 31, 2014 | -6 | +20.88% |
| Dec 31, 2013 | -5 | +266.78% |
| Dec 31, 2012 | -1 | +119.59% |
| Dec 31, 2011 | -1 |